ICI 118,551 hydrochloride
CAS No. 72795-01-8
ICI 118,551 hydrochloride ( ICI 118551 hydrochloride )
Catalog No. M24738 CAS No. 72795-01-8
ICI 118,551?is a highly selective β2 adrenergic receptor antagonist (Kis: 0.7, 49.5, and 611 nM for β2, β1, and β3 receptors).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 46 | In Stock |
|
100MG | Get Quote | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameICI 118,551 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionICI 118,551?is a highly selective β2 adrenergic receptor antagonist (Kis: 0.7, 49.5, and 611 nM for β2, β1, and β3 receptors).
-
DescriptionICI 118,551?is a highly selective β2 adrenergic receptor antagonist (Kis: 0.7, 49.5, and 611 nM for β2, β1, and β3 receptors).
-
SynonymsICI 118551 hydrochloride
-
PathwayOthers
-
TargetOther Targets
-
Recptorβ2 receptor;β1 receptor;β3 receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number72795-01-8
-
Formula Weight313.9
-
Molecular FormulaC17H28ClNO2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 20 mg/mL (63.72 mM; Need ultrasonic) H2O : 11 mg/mL (35.05 mM; Need ultrasonic)
-
SMILESCC1=C(CCC2)C2=C(OC[C@H](O)[C@@H](C)NC(C)C)C=C1.[H]Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yasuda G, et al. The beta 1- and beta 2-adrenoceptor subtypes in cultured rat inner medullary collecting duct cells. Am J Physiol. 1996 Sep;271(3 Pt 2):F762-9.
molnova catalog
related products
-
Acetyl hexapeptide 3...
Acetyl hexapeptide 38, breast enhancement peptide, is a kind of acetylated hexapeptide, can significantly stimulate the use of the site of fat synthesis, increase the volume of the chest or cheek, shape the perfect body
-
Z-Phe-Ala-NH2
Heterocyclic Organic Compound
-
Grandifloroside
Grandifloroside shows good antioxidative and potent anti-inflammatory activities, it also exhibits potent inhibitory activity against TNF-α and 5α-reductase, suggests that it might be developed as a source of potent anti-oxidative and anti-inflammatory agents and therapeutic agent for benign prostatic hypertrophy (BPH).